Cancer Diagnostics Market Trends and Forecast 2025 | Abbott Laboratories, AstraZeneca, Ambry Genetics, Eli Lilly and Co
With the tremendous rise in the prevalence of cancer across the world, the global market for cancer diagnostics is witnessing a remarkable surge in its size. The technological advancements in devices used in the diagnosis of cancer are also supporting the growth of this market, significantly. One of the main causes of deaths, globally, is cancer. Therefore, medical and healthcare professionals are concentrating on the development of efficient diagnostic and treatment solutions to control the prevalence rate. Since, the early diagnosis increases the success ratio of treatment regimens, medical and healthcare agencies and device vendors through several awareness programs are encouraging routine checkups for cancer diagnosis, worldwide. This, in turn, is likely to boost the global market substantially in the years to come.
Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1949
The global market for cancer diagnostics is led by imaging devices, in terms of products. Thanks to the advent of imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT) scan, this product segment is expected to remain on the top over the next few years. Among the types of tests, laboratory and genetic tests have been leading the global market and is projected to continue doing so in the years to come. North America, among regional markets, has acquired the dominant position, thanks to the presence of a well-established medical and healthcare infrastructure. Researchers anticipate this scenario to remain the same over the forthcoming years. Asia Pacific and Europe, among other regional markets, are also projected to witness high growth in the near future, thanks to the presence of lucrative growth opportunities.
Global Cancer Diagnostics Market: Overview
Cancer, caused by environmental factors causing gene mutations and affecting cell regulatory proteins, is one of the diseases that is resulting in the highest expenditure for treatment. Growing incidences of cancer is fueling the market for cancer diagnostics at an exponential rate. Advancements in technology coupled with growing government funding, and initiatives for research and development have resulted in the positive growth of the global cancer diagnostics market. As per the World Health Organization, the number of deaths reported due to cancer was 8.2 mn in 2012. In addition to this, 14 mn new cases are being registered across the globe. All these factors are expected to push the demand for cancer diagnostics.
Cancer can be diagnosed by using diagnostic devices which not only confirms the presence of tumor, but also gives information regarding the rate at which it is growing inside the body. This is boosting the global demand for cancer diagnostic devices.
Global Cancer Diagnostics: Key Trends
The advent of proteomics, genomics, metabolomics, transcriptomics and other such breakthrough detection techniques is expected to fuel the demand for cancer diagnostic devices. Additionally, the breakthrough development in companion diagnostics is also expected to create positive environment for an increase in the demand for cancer diagnostic devices. Some of the other factors anticipated to drive this market is the rise in the awareness level of patients and an increase in the number of screenings, which in turn is leading to an early diagnosis of cancer and increasing the chances of survival. However, there are various factors that are affecting the demand for these devices. Some of them include, the high cost of medical laboratory infrastructure, insufficient reimbursement for innovative technologies, and strict guidelines and procedures implemented by government.
Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1949
Global Cancer Diagnostics: Market Potential
Cancer diagnostic devices are being used by pharmaceutical companies for monitoring, administering, and diagnosing the cancer treatment process. Pharmaceutical companies such as Roche are shifting their focus from developing drugs to diagnostic devices. Roche’s cobas EGFR mutation test helps in the diagnosis of neck and head cancers.
Scientific advancements have made possible complex and customized approach to cancer in molecular diagnostics. Abbott Molecular is one of the key players in oncology molecular diagnostics and has developed Vysis FISH assays, which offers features such as processing flexibility, reduced inventory management, and simplified workflow. All these factors help to reduce operating costs. Such developments are helping the growth and progress of the global cancer diagnostics market.
Global Cancer Diagnostics Market: Regional Outlook
In terms of geography, North America, followed by Europe is leading in the cancer diagnostics market. The adoption rate of preventive diagnostic techniques is high, fueled by increasing government efforts to create awareness about cancer. Other factors pushing the demand for cancer diagnostic devices in the region include, growing prevalence of breast, lung, and prostate cancer in these regions.
As per the report, Asia Pacific is also expected to witness a positive growth in the forecast period with developed nations such as Australia and Japan as well as developing nations such as China, Thailand, Singapore, and India creating opportunities of growth for the cancer diagnostics market.
Read Comprehensive Overview of Report @ https://www.tmrresearch.com/cancer-diagnostics-market
Global Cancer Diagnostics Market: Competitive Landscape
Some of the key vendors operating in the global cancer diagnostics market are: Abbott Laboratories, AstraZeneca, Ambry Genetics, Eli Lilly and Co., bioMerieux, Roche, GlaxoSmithKline plc, Pfizer, and Novartis.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Diagnostics Market Trends and Forecast 2025 | Abbott Laboratories, AstraZeneca, Ambry Genetics, Eli Lilly and Co here
News-ID: 2130622 • Views: 342
More Releases from TMR Research
Recycled Thermoplastic Market Insights By Growth, Emerging Trends And Forecast B …
Recycled Thermoplastic Market: Snapshot The demand within the global recycled thermoplastic market has been rising on account of advancements in the energy sector. The use of thermoplastics across a wide array of industries has given a thrust to the growth of the global market. Moreover, the superiority of recycled thermoplastics over thermosets has also given a strong push to the growth of the global market. There have been key advancements in
Smart Card Materials Market Projected to Witness a Double-Digit CAGR During 2028
Global Smart Card Materials Market: Snapshot The global market smart card has gained phenomenal momentum in recent years due to increasing usage of smart cards in various industries for various purposes. The growing popularity of smart cards due to the convenience they offer for identification, cashless payments, and tracking amongst other things. Proliferation of BFSI industry that has seen a constant rise in its consumer base has prompted many smart card
Taxifolin Market Dynamic Business Environment During Forecast 2018 – 2028
Taxifolin Market: Snapshot Taxifolin or dihydroquercetin is a flavonoid that acts as a potential chemopreventive agent. It helps in the regulation of genes through an ARE-dependent mechanism. Primarily, taxifolin has the properties to slow down the cell growth of ovarian cancer. It can be found across many products and beverages. Particularly, taxifolin can be found across plant-based foods such as vegetables, wine, cocoa, and fruits. Conifers such as Siberian larch and
Nafion Market Promising Growth Opportunities & Forecast 2019-2029
Nafion Market: Snapshot Nafion is a sophisticated name for sulfonated tetrafluoroethylene based fluoropolymer-copolymer. It was first discovered by Walter Grot of DuPont back in the 1960s. Nafion is a first synthetic polymer that possesses ionic properties that are known as ionomers. Nafion has unique ionic features because of the incorporation of perfluorovinyl ether groups with terminated sulfonate groups onto a PTFE backbone. Nafion can also act as a cation exchange polymer
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,
Mesothelioma: The “Orphan” Cancer
Government funding remains elusive for deadly disease Newton, MA. Oct. 1st 2007. While Americans have long been romanced by campaigns for breast cancer and leukemia research, it may be some time before mesothelioma enjoys a stint in the spotlight. Despite the fact that over 2,500 cases of the disease are diagnosed in the U.S. each year—with as many or more dying from it—the need to develop effective treatments for mesothelioma victims